Compare CDNA & FLOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDNA | FLOC |
|---|---|---|
| Founded | 1998 | 1996 |
| Country | United States | United States |
| Employees | N/A | 1281 |
| Industry | Medical Specialities | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 944.8M |
| IPO Year | 2007 | N/A |
| Metric | CDNA | FLOC |
|---|---|---|
| Price | $20.44 | $27.60 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 4 |
| Target Price | $28.00 | ★ $28.50 |
| AVG Volume (30 Days) | ★ 600.1K | 570.9K |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 1.31% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $48,324,000.00 | N/A |
| Revenue This Year | $16.01 | $22.92 |
| Revenue Next Year | $11.31 | $8.59 |
| P/E Ratio | $412.00 | ★ $16.57 |
| Revenue Growth | ★ 18.93 | N/A |
| 52 Week Low | $10.96 | $14.03 |
| 52 Week High | $23.24 | $27.85 |
| Indicator | CDNA | FLOC |
|---|---|---|
| Relative Strength Index (RSI) | 50.55 | 70.60 |
| Support Level | $18.20 | $15.04 |
| Resistance Level | $21.20 | N/A |
| Average True Range (ATR) | 1.04 | 1.10 |
| MACD | -0.22 | 0.20 |
| Stochastic Oscillator | 30.73 | 93.18 |
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
Flowco Holdings Inc is a provider of production optimization, artificial lift, emissions management, and monetization solutions for the oil and natural gas industry. Its technologies include high-pressure gas lift (HPGL), conventional gas lift, plunger lift, and vapor recovery unit (VRU) solutions. The company operates in two reportable segments: Production Solutions, which includes rental services, and Natural Gas Technologies, which include service, gas compression parts, and equipment sales. Production Solutions: relates to rentals, sales, and services related to high-pressure gas lift, conventional gas lift, and plunger lift; including other digital solutions and methane abatement technologies, and has maximum revenue. It generates maximum revenue from the United States.